Phibro Animal Health Corp (NASDAQ:PAHC) VP Daniel M. Bendheim sold 5,000 shares of Phibro Animal Health stock in a transaction dated Wednesday, January 9th. The shares were sold at an average price of $32.43, for a total value of $162,150.00. Following the completion of the transaction, the vice president now owns 2,500 shares in the company, valued at approximately $81,075. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of NASDAQ PAHC opened at $33.11 on Friday. The company has a debt-to-equity ratio of 1.62, a current ratio of 3.26 and a quick ratio of 1.82. The stock has a market capitalization of $1.33 billion, a price-to-earnings ratio of 19.03, a price-to-earnings-growth ratio of 3.32 and a beta of 0.75. Phibro Animal Health Corp has a fifty-two week low of $30.79 and a fifty-two week high of $54.62.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Tuesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.03). The business had revenue of $200.20 million during the quarter, compared to analyst estimates of $203.99 million. Phibro Animal Health had a return on equity of 38.91% and a net margin of 7.89%. Phibro Animal Health’s revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.38 EPS. On average, equities analysts anticipate that Phibro Animal Health Corp will post 1.71 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.45%. The ex-dividend date of this dividend was Tuesday, November 27th. This is an increase from Phibro Animal Health’s previous quarterly dividend of $0.10. Phibro Animal Health’s dividend payout ratio (DPR) is currently 27.59%.

Several equities analysts have issued reports on the company. BidaskClub upgraded Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research note on Tuesday, December 18th. Zacks Investment Research lowered Phibro Animal Health from a “hold” rating to a “strong sell” rating in a research note on Wednesday, October 24th. Finally, ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Monday, November 12th. Two investment analysts have rated the stock with a sell rating and four have given a hold rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $43.50.

Hedge funds and other institutional investors have recently modified their holdings of the business. BlueMountain Capital Management LLC boosted its holdings in Phibro Animal Health by 60.4% in the second quarter. BlueMountain Capital Management LLC now owns 22,454 shares of the company’s stock worth $1,034,000 after acquiring an additional 8,451 shares in the last quarter. Granite Investment Partners LLC boosted its holdings in Phibro Animal Health by 4.3% in the third quarter. Granite Investment Partners LLC now owns 326,391 shares of the company’s stock worth $14,003,000 after acquiring an additional 13,413 shares in the last quarter. First Trust Advisors LP boosted its holdings in Phibro Animal Health by 20.0% in the second quarter. First Trust Advisors LP now owns 22,586 shares of the company’s stock worth $1,040,000 after acquiring an additional 3,769 shares in the last quarter. Janus Henderson Group PLC acquired a new stake in Phibro Animal Health in the second quarter worth about $222,000. Finally, BlackRock Inc. boosted its holdings in Phibro Animal Health by 7.7% in the second quarter. BlackRock Inc. now owns 3,304,441 shares of the company’s stock worth $152,169,000 after acquiring an additional 235,932 shares in the last quarter. 49.62% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Phibro Animal Health Corp (PAHC) VP Daniel M. Bendheim Sells 5,000 Shares” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.thecerbatgem.com/2019/01/12/phibro-animal-health-corp-pahc-vp-daniel-m-bendheim-sells-5000-shares.html.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Recommended Story: How does a reverse stock split work?

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.